Immuno-oncology

Kähkönen TE, Halleen JM, MacRitchie G, Andersson R, Bernoulli J 2023 Insights into immuno-oncology drug development landscape with focus on bone metastasis. Front. Immunol. 14. https://doi.org/10.3389/fimmu.2023.1121878

Kähkönen TE, Halleen JM, Bernoulli J 2022 Preclinical Osteoimmuno-Oncology Models to Study Effects of Immunotherapies on Bone Metastasis. Chapter in the book Animal Models for the Development of Cancer Immunotherapy, pages 167-209. John Wiley & Sons, Inc.

Kähkönen TE, Halleen JM, Bernoulli J 2021 Osteoimmuno-Oncology: Therapeutic Opportunities for Targeting Immune Cells in Bone Metastasis. Cells 10(6), 1529; https://doi.org/10.3390/cells10061529

Kähkönen TE, Halleen JM, Bernoulli J 2020 Immunotherapies and metastatic cancers: understanding utility and predictivity of human immune cell engrafted mice in preclinical drug development. Cancers 12(6):1615 (invited review article).

Kähkönen TE, Halleen JM, Bernoulli J 2019 Potential of Targeting Bone Metastases with Immunotherapies. Nov Appro In Can Study 3(3):269-270 (invited review article).

Kähkönen TE, Suominen MI, Mäki-Jouppila JHE, Halleen JM, Tanaka A, Seiler M, Bernoulli J 2019 Human Immune System Increases Breast Cancer-Induced Osteoblastic Bone Growth in a Humanized Mouse Model without Affecting Normal Bone. J Immunol Res 2019/4260987.